LivaNova (LIVN) FCF Margin Growth (3y) (2019 - 2026)
LivaNova (LIVN) FCF Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | -2,196.00 |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | -472.00 |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 2,679.00 |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | -20.00 |
| 10 | LivaNova | 4.37 Bn | 3.83 Bn | 243.75 Mn | -365.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -365.00 |
| Dec 31, 2025 | 1,042.00 |
| Sep 30, 2025 | 566.00 |
| Jun 30, 2025 | 1,999.00 |
| Mar 31, 2025 | -442.00 |
| Dec 31, 2024 | 1,163.00 |
| Sep 30, 2024 | 216.00 |
| Jun 30, 2024 | 252.00 |
| Mar 31, 2024 | -333.00 |
| Dec 31, 2023 | 195.00 |
| Sep 30, 2023 | 406.00 |
| Jun 30, 2023 | 755.00 |
| Mar 31, 2023 | 5,226.00 |
| Dec 31, 2022 | 523.00 |
| Sep 30, 2022 | 4,246.00 |
| Jun 30, 2022 | 238.00 |
| Mar 31, 2022 | 1,008.00 |
| Dec 31, 2021 | 689.00 |
| Sep 30, 2021 | -625.00 |
| Jun 30, 2021 | -21.00 |